International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study

Abstract

Hyperpolypharmacy is common among older people with advanced CKD, with significant international differences in the number of medications prescribed. Practice variation may represent a lack of consensus regarding appropriate prescribing for this high-risk group for whom pharmacological treatment has great potential for harm as well as benefit.